Jansen B - Search Results

1

Mcl-1 blocks radiation-induced apoptosis and inhibits clonogenic cell death.

Skvara H, Thallinger C, Wacheck V, Monia BP, Pehamberger H, Jansen B, Selzer E. Skvara H, et al. Among authors: jansen b. Anticancer Res. 2005 Jul-Aug;25(4):2697-703. Anticancer Res. 2005. PMID: 16080514 Free article.

2

Bcl-X(L) is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy.

Heere-Ress E, Thallinger C, Lucas T, Schlagbauer-Wadl H, Wacheck V, Monia BP, Wolff K, Pehamberger H, Jansen B. Heere-Ress E, et al. Among authors: jansen b. Int J Cancer. 2002 May 1;99(1):29-34. doi: 10.1002/ijc.10248. Int J Cancer. 2002. PMID: 11948488

3

Betulinic acid-induced Mcl-1 expression in human melanoma--mode of action and functional significance.

Selzer E, Thallinger C, Hoeller C, Oberkleiner P, Wacheck V, Pehamberger H, Jansen B. Selzer E, et al. Among authors: jansen b. Mol Med. 2002 Dec;8(12):877-84. Mol Med. 2002. PMID: 12606824 Free PMC article.

4

Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation model.

Thallinger C, Wolschek MF, Wacheck V, Maierhofer H, Günsberg P, Polterauer P, Pehamberger H, Monia BP, Selzer E, Wolff K, Jansen B. Thallinger C, et al. Among authors: jansen b. J Invest Dermatol. 2003 Jun;120(6):1081-6. doi: 10.1046/j.1523-1747.2003.12252.x. J Invest Dermatol. 2003. PMID: 12787138 Free article.

5

Mcl-1 is a novel therapeutic target for human sarcoma: synergistic inhibition of human sarcoma xenotransplants by a combination of mcl-1 antisense oligonucleotides with low-dose cyclophosphamide.

Thallinger C, Wolschek MF, Maierhofer H, Skvara H, Pehamberger H, Monia BP, Jansen B, Wacheck V, Selzer E. Thallinger C, et al. Among authors: jansen b. Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4185-91. doi: 10.1158/1078-0432.CCR-03-0774. Clin Cancer Res. 2004. PMID: 15217956

6

Effects of betulinic acid alone and in combination with irradiation in human melanoma cells.

Selzer E, Pimentel E, Wacheck V, Schlegel W, Pehamberger H, Jansen B, Kodym R. Selzer E, et al. Among authors: jansen b. J Invest Dermatol. 2000 May;114(5):935-40. doi: 10.1046/j.1523-1747.2000.00972.x. J Invest Dermatol. 2000. PMID: 10771474 Free article.

7

The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanoma.

Selzer E, Wacheck V, Lucas T, Heere-Ress E, Wu M, Weilbaecher KN, Schlegel W, Valent P, Wrba F, Pehamberger H, Fisher D, Jansen B. Selzer E, et al. Among authors: jansen b. Cancer Res. 2002 Apr 1;62(7):2098-103. Cancer Res. 2002. PMID: 11929831

8

Bcl-xL antisense oligonucleotides chemosensitize human glioblastoma cells.

Guensberg P, Wacheck V, Lucas T, Monia B, Pehamberger H, Eichler HG, Jansen B. Guensberg P, et al. Among authors: jansen b. Chemotherapy. 2002 Sep;48(4):189-95. doi: 10.1159/000063873. Chemotherapy. 2002. PMID: 12218266

9

Antitumor effect of G3139 Bcl-2 antisense oligonucleotide is independent of its immune stimulation by CpG motifs in SCID mice.

Wacheck V, Krepler C, Strommer S, Heere-Ress E, Klem R, Pehamberger H, Eichler HG, Jansen B. Wacheck V, et al. Among authors: jansen b. Antisense Nucleic Acid Drug Dev. 2002 Dec;12(6):359-67. doi: 10.1089/108729002321082438. Antisense Nucleic Acid Drug Dev. 2002. PMID: 12568310

10

Small interfering RNA targeting bcl-2 sensitizes malignant melanoma.

Wacheck V, Losert D, Günsberg P, Vornlocher HP, Hadwiger P, Geick A, Pehamberger H, Müller M, Jansen B. Wacheck V, et al. Among authors: jansen b. Oligonucleotides. 2003;13(5):393-400. doi: 10.1089/154545703322617078. Oligonucleotides. 2003. PMID: 15000830

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

702 results

Search Page

Filters